Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allarity Therapeutics (ALLR) Total Debt (2024)

Allarity Therapeutics' Total Debt history spans 1 years, with the latest figure at $1000.0 for Q4 2024.

  • For Q4 2024, Total Debt changed N/A year-over-year to $1000.0; the TTM value through Dec 2024 reached $1000.0, changed N/A, while the annual FY2024 figure was $1000.0, N/A changed from the prior year.
  • Total Debt reached $1000.0 in Q4 2024 per ALLR's latest filing, down from $2000.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $2.7 million in Q1 2024 to a low of $1000.0 in Q4 2024.